Organization | Sumitomo

Sumitomo Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4

Founded: Ehime Japan (1986)

Status: Acquired by Sumitomo Dainippon (2005)

Organization Overview

First Clinical Trial

2008

NCT00660504

First Marketed Drug

2013

eslicarbazepine acetate (aptiom)

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

SUMITOMO PHARMA AM | Sumitomo Pharmaceuticals America | Sumitomo Pharmaceutical (Suzhou) Co., Ltd. | Sumitomo Pharma Co., Ltd. | Sumitomo Pharma (Suzhou) Co., Ltd.

Active Ingredients

Marketed Drugs (3)

apomorphine (apokyn) (2020)

eslicarbazepine acetate (aptiom) (2013)

glycopyrronium (robinul) (2017)

Drugs in Phase 4 Trials (11)

Key: Sumitomo (10) Acquired (1)

arotinolol (2 trials)

blonanserin (Lonasen) (2 trials)

domperidone (1 trial)

imeglimin (Twymeeg) (1 trial)

lurasidone (latuda) (6 trials)

metformin (glucophage) (1 trial)

metoprolol (lopressor) (1 trial)

mosapride (1 trial)

tandospirone (1 trial)

tapinarof (Vtama) (11 trials)

vildagliptin (1 trial)

Drugs in Phase 3 Trials (6)

amrubicin (1 trial)

cisplatin (platinol) (1 trial)

etoposide (vepesid) (1 trial)

icosapent ethyl (vascepa) (1 trial)

risperidone (risperdal) (2 trials)

Ulotaront (2 trials)

Drugs in Phase 2 Trials (9)

Key: Sumitomo (2) Acquired (7)

azacitidine (vidaza) (1 trial)

cerdulatinib (1 trial)

cromoglicic acid (Intal) (2 trials)

e6005 (1 trial)

gimsilumab (2 trials)

Drugs in Phase 1 Trials (9)

Key: Sumitomo (2) Acquired (7)

DSP-9632P (1 trial)

ketamine (ketalar) (1 trial)

ksp-1007 (1 trial)

levodopa (larodopa) (1 trial)

meropenem (merrem) (1 trial)

pembrolizumab (keytruda) (1 trial)

rodatristat ethyl (1 trial)

snx281 (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Anxiety Disorders (Phase 4)

Depression (Phase 3)

Depressive Disorder (Phase 3)

Disease (Phase 4)

Essential Hypertension (Phase 4)

Gastroparesis (Phase 4)

Hypertension (Phase 4)

Hypertriglyceridemia (Phase 3)

Kidney Diseases (Phase 4)

Leukemia (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Lung Neoplasms (Phase 3)

Renal Insufficiency, Chronic (Phase 4)

Schizophrenia (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 45
# of Trial APIs: 35